UCT Lung Institute
Cape Town, South Africa
Research institute in Cape Town
University of Cape Town Lung Institute, George Street, Mowbray, Cape Town, 7700
About UCT Lung Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Global Alliance for TB Drug Development
4
Boehringer Ingelheim
3
AIDS Clinical Trials Group
2
National Institute of Allergy and Infectious Diseases (NIAID)
2
Statens Serum Institut
2
Aeras
1
BioMérieux
1
Foundation for Innovative New Diagnostics, Switzerland
1
Galapagos NV
1
Genentech, Inc.
1
Clinical Trials at UCT Lung Institute
During the past decade, UCT Lung Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 10 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care
2003-05-01
2006-12-01
Unknown status
39
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
2003-11-01
2004-09-01
Completed
605
12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD
2002-11-01
Completed
429
Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)
2003-09-01
2004-08-01
Completed
107
A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)
2011-04-01
2011-12-01
Completed
253
Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
2011-04-01
2013-06-01
Completed
446
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
2012-03-01
2013-07-01
Completed
207
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UCT Lung Institute" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Global Alliance for TB Drug Development" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "AIDS Clinical Trials Group" with 2 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)"
with 2 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UCT Lung Institute"
#1 collaborator was "University of Cape Town Lung Institute" with 3 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Statens Serum Institut" with 2 trials as a collaborator and "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were
collaborators in the rest 32 trials.
Clinical Trials Conditions at UCT Lung Institute
According to Clinical.Site data, the most researched conditions in "UCT Lung Institute" are
"Tuberculosis" (9 trials), "Asthma" (4 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Pulmonary Disease, Chronic Obstructive" (3 trials) and "Pulmonary Tuberculosis" (2 trials). Many other conditions were trialed in "UCT Lung Institute" in a lesser frequency.
Clinical Trials Intervention Types at UCT Lung Institute
Most popular intervention types in "UCT Lung Institute" are "Drug" (24 trials), "Biological" (5 trials), "Device" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Pyrazinamide" (4 trials), "Moxifloxacin" (3 trials), "PA-824" (3 trials) and "C-Tb" (2 trials). Other intervention names were less common.
Clinical Trials Genders at UCT Lung Institute
The vast majority of trials in "UCT Lung Institute" are
36 trials for "All" genders.
Clinical Trials Status at UCT Lung Institute
Currently, there are NaN active trials in "UCT Lung Institute".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in UCT Lung Institute,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UCT Lung Institute, 4 "Phase 1"
clinical trials were conducted, 17 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".